Cooley, Latham Prep Electra Therapeutics' $325M IPO Plan
Biotechnology firm Electra Therapeutics plans to make its public debut this week through an estimated $325 million initial public offering steered by Cooley LLP and Latham & Watkins LLP....To view the full article, register now.
Already a subscriber? Click here to view full article